Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study
Journal of Diabetes Investigation · 2024
DOI: 10.1111/jdi.14134 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Yi-Cheng Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Renal Insufficiency, Chronic, Atherosclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science and Technology Council.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/Introduction Cardiovascular mortality risk is elevated among patients with diabetes and concurrent chronic kidney disease. However, controversy surrounds the use of aspirin for primary prevention within this population. This study aims to assess the effectiveness and safety of low‐dose aspirin for primary prevention in patients with diabetes and pre‐end‐stage renal disease. Materials and Methods This was a retrospective population‐based cohort study using the National Health Insurance Research Database in Taiwan. The study included adults with type 2 diabetes who were enrolled in the pre‐end‐stage renal disease pay‐for‐performance program and had no atherosclerotic cardiovascular disease. We used propensity score analysis to control baseline characteristics between the two groups. Clinical outcomes including cardiovascular mortality, all‐cause mortality, major bleeding, and renal disease progression were compared between patients who first received aspirin and those who did not.
Results
Between January 2012 and December 2015, a total of 2,155 low‐dose aspirin users and 6,737 nonaspirin users were identified. Following propensity score adjustment, aspirin use exhibited a comparable risk of cardiovascular death compared with nonaspirin users (adjusted hazard ratio [aHR] 1.12; 95% confidence interval [CI] 0.65–1.95; P = 0.681). The risk of all‐cause mortality was similar between the two groups (aHR 1.07; 95% CI 0.92–1.24; P = 0.385). Similar risks were observed in terms of major bleeding and renal disease progression.
Conclusions
In patients with diabetes and pre‐end‐stage renal disease who lacked atherosclerotic cardiovascular disease, low‐dose aspirin did not demonstrate a reduction in mortality. These findings do not support the use of aspirin for primary prevention in this high‐risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan.
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
- Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, New Taipei City, Taiwan.
- Institute of Health and Welfare Policy, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
- Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
ORCID-Profile: Yi-Cheng Lin
Förderung
- National Science and Technology Council
Zitieren
APA
Lin, Y. C., Chen, B. L., Chen, W. T., Chien, L. N., & Huang, C. Y. (2024). Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14134
Vancouver
Lin YC, Chen BL, Chen WT, Chien LN, Huang CY. Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14134
BibTeX
@article{Lin2024,
author = {Lin, Yi-Cheng and Chen, Bi-Li and Chen, Wan-Ting and Chien, Li-Nien and Huang, Chun-Yao},
title = {Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study},
journal = {Journal of Diabetes Investigation},
year = {2024},
doi = {10.1111/jdi.14134}
}
EUVIMED